Novasep is a leading worldwide provider of integrated manufacturing solutions for the life science industries. We develop, market and operate innovative technologies from lab to industrial scale to produce biomolecules and synthetic molecules for the pharmaceutical, biopharmaceutical, agrochemical, fine chemical and industrial biotechnology markets.
In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model, which includes:
Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.
We operate through two complementary business divisions, Novasep Process and Novasep Synthesis.
Our offering for synthetic molecules consists of: multi-step synthesis and purification of active pharmaceutical ingredients (APIs) and advanced intermediates, agrochemicals and fine chemicals; purification processes, equipment and products for APIs, synthetic peptides and fine chemicals; as well as special reagents, building blocks and generic APIs.
Our offering for biomolecules consists of: upstream and downstream processing, formulation and fill and finish of biopharmaceuticals; production of functional ingredients; purification processes, systems and consumables for biopharmaceutical, food, functional and bio-industrial applications.
Our customers benefit from our process intelligence:
The company has six FDA inspected manufacturing plants in France, Germany and the Bahamas; two biopharmaceutical production sites in Belgium; R&D and equipment manufacturing facilities in the USA, China and France; and an office in Japan. It employs approximately 1,200 people and had annual revenues of EUR300 million in 2010. More than 2,000 systems designed and produced by Novasep are currently purifying active molecules throughout the world.
81 Boulevard de la Moselle
BP 50 – 54340 Pompey
Tel: +33 3 83 49 71 00
Fax: +33 3 83 49 71 02